1. Home
  2. SMID vs ENLV Comparison

SMID vs ENLV Comparison

Compare SMID & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$29.40

Market Cap

157.6M

Sector

Industrials

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.51

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
ENLV
Founded
1960
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.6M
149.0M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
SMID
ENLV
Price
$29.40
$0.51
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
13.3K
344.8K
Earning Date
04-14-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
62.76
N/A
EPS
0.25
N/A
Revenue
$93,446,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$118.16
N/A
Revenue Growth
19.03
N/A
52 Week Low
$25.60
$0.51
52 Week High
$43.62
$2.10

Technical Indicators

Market Signals
Indicator
SMID
ENLV
Relative Strength Index (RSI) 48.78 23.78
Support Level $26.74 N/A
Resistance Level $36.74 $1.25
Average True Range (ATR) 1.49 0.05
MACD 0.08 -0.01
Stochastic Oscillator 44.35 18.34

Price Performance

Historical Comparison
SMID
ENLV

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: